Erratum to: Does Adding Transdermal Nitroglycerine to Other Therapies Used for Management of Left-sided Congestive Heart Failure in Dogs Speed the Resolution of Clinical Signs?Jenefer R Stillion DVM, DACVECC1
1Western Veterinary Specialist and Emergency Centre, Calgary, Canada
2Department of Veterinary Clinical and Diagnostic Sciences, Faculty of Veterinary Medicine, University of Calgary, Calgary, Canada
*Corresponding Author (email@example.com)
Vol 3, Issue 1 (2018)
Erratum published: 01 Feb 2018
Original paper published: 12 Dec 2017
The original article was published in Veterinary Evidence Vol 2, Issue 4 (2017): http://dx.doi.org/10.18849/ve.v2i4.115
Unfortunately the original version of the article had the following two errors.
Within the Exclusion/Inclusion Criteria table the inclusion section was changed from:
Transdermal, OR cutaneous, OR ointment, AND dog OR dogs OR canine OR bitch* OR canis OR bitches AND heart OR cardiac OR CHF OR cardio* OR left ventricular OR left ventricle* OR LV OR heart diseases OR cardiovascular diseases AND glyceryl trinitrat* OR glyceryltrinitrat* OR trinity glycerin* OR nitro glycerin* OR nitroglycerin*
Any relevant primary veterinary research or systematic review which compared transdermal nitroglycerine to other therapies to answer the following question; “Does adding transdermal nitroglycerine to other therapies used for management of left-sided congestive heart failure in dogs speed the resolution of clinical signs?”
This error was in both the HTML and PDF versions. This has now been updated in both the HTML and PDF versions.
Within the Search Outcome table for NCBI PubMed the number of results under ‘Excluded did not address the PICO’ was incorrectly inputted as 10. The number should have been 6.
This error was in the HTML version only. This has now been updated in the HTML version.
Intellectual Property Rights
Authors of Knowledge Summaries submitted to RCVS Knowledge for publication will retain copyright in their work, and will be required to grant to RCVS Knowledge a non-exclusive licence of the rights of copyright in the materials including but not limited to the right to publish, re-publish, transmit, sell, distribute and otherwise use the materials in all languages and all media throughout the world, and to licence or permit others to do so.